SCHEMBL8860185

SCHEMBL8860185

CC1C(=O)N(Nc2ccncc2F)c2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
TGFBR1 P36897 6/20 0.34
TGFBR2 P37173 6/20 0.34
BRD4 O60885 1/20 0.33
CCL2 P13500 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRK1 P41145 1/20 0.33
OPRL1 P41146 1/20 0.33
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
PDE4B Q07343 2/20 0.32
PDE7A Q13946 2/20 0.32
LMNA P02545 3/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CACNA1G O43497 1/20 0.32
CACNA1H O95180 1/20 0.32
CACNA1I Q9P0X4 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8860374 0.79 LMNA (0.38) MEN1MAPTKMT2ABRD4CCL2
SCHEMBL9206531 0.73 ROCK1 (0.37) TGFBR1TGFBR2LMNASMN1; SMN2CACNA1G
SCHEMBL7474470 0.73 CYP1A2 (0.46) MEN1KMT2ALMNASMN1; SMN2
SCHEMBL8860096 0.72 HPGD (0.37) MEN1MAPTKMT2ATGFBR1TGFBR2
SCHEMBL8872035 0.66 AOC1 (0.33) LMNA
SCHEMBL7608055 0.64 TGFBR1 (0.38) TGFBR1TGFBR2BCHEACHE
SCHEMBL9206437 0.63 ROCK1 (0.37) CACNA1GCACNA1HCACNA1IKDM4C
SCHEMBL9311407 0.63 HTR2C (0.40) MEN1MAPTKMT2ALMNASMN1; SMN2
SCHEMBL9663897 0.62 SLC6A2 (0.56) TGFBR1TGFBR2BCHEACHE
SCHEMBL7480165 0.62 TGFBR1 (0.35) MAPTTGFBR1TGFBR2BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0415102-B1 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-ones, a process for their preparation and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1995-02-01 EP claimed
US-5053511-A Analgesics; anticonvulsants; treatment for alzheimers disease HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-10-01 US claimed
EP-0415102-A1 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-ones, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-03-06 EP claimed
US-5686626-A COGNITION ACTIVATORS HOECHST MARION ROUSSEL, INC. (US) 1997-11-11 US disclosed
US-5621116-A CHEMICAL INTERMEDIATES; MEMORY ENHANCERS FOR TREATMENT OF ALZHEIMER*S, ANALGESICS, ANTICONVULSANTS HOECHST MARION ROUSSEL, INC. (US) 1997-04-15 US disclosed
US-5464846-A Learning enhancement, Alzheimer's disease HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1995-11-07 US disclosed
EP-0415102-B1 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-ones, a process for their preparation and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1995-02-01 EP disclosed
US-5179119-A Cognition activators; alzheimer*s disease HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-01-12 US disclosed
US-5053511-A Analgesics; anticonvulsants; treatment for alzheimers disease HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-10-01 US disclosed
EP-0415102-A1 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-ones, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-03-06 EP disclosed